Recommendations for the prevention and control of methicillin-resistant Staphylococcus aureus strains (MRSA) in medical and nursing facilities: Recommendation of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute;Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen: Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 57, Issue 6, 2014, Pages 695-732

  Ruscher, C ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956913321     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-014-1980-x     Document Type: Article

References (434)

1. Chen LF (2013) The changing epidemiology of methicillin-resistant Staphylococcus aureus: 50 years of a superbug. Am J Infect Control 41:448–451
2. Klevens RM, Morrison MA, Nadle J et al (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771
3. GERMAP 2010 Antibiotika-Resistenz und -Verbrauch (2010) Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg. Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH
4. The European Centre for Disease Prevention and Control (ECDC), Antimicrobial resistance interactive database (EARS-Net) (2012). http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx. Zugegriffen: April 2014
5. Kommission für Krankenhaushygiene und Infektionsprävention (2005) Infektionsprävention in Heimen. Bundesgesundheitsblatt 48:1061–1080
6. Muto CA, Jernigan JA, Ostrowsky BE et al (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386
7. Korczak D, Schöffmann C (2010) Medizinische Wirksamkeit und Kosten-Effektivität von Präventions- und Kontrollmaßnahmen gegen Methicillin-resistente Staphylococcus aureus (MRSA)-Infektionen im Krankenhaus. GMS Health Technol Assess 6:Doc04
8. Cooper BS, Stone SP, Kibbler CC et al (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 7:1–194
9. Siegel JD, Rhinehart E, Jackson M et al (2007) 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35:S65–S164
10. Siegel JD, Rhinehart E, Jackson M et al (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35:S165–S193
11. Strausbaugh LJ, Siegel JD, Weinstein RA (2006) Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 42:828–835
12. Kommission für Krankenhaushygiene und Infektionsprävention (1999) Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsblatt 42:954–958
13. Kommission für Krankenhaushygiene und Infektionsprävention (2008) Kommentar zu den „Empfehlungen zur Prävention und Kontrolle von MRSA-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen“. Epidemiol Bull 42:363–364
14. Kommission für Krankenhaushygiene und Infektionsprävention (2002) Ausbruchmanagement und struktuiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen. Bundesgesundheitsblatt 45:180–186
15. Kommission für Krankenhaushygiene und Infektionsprävention (2000) Empfehlungen zur Händehygiene. Bundesgesundheitsblatt 43:230–233
16. Kommission für Krankenhaushygiene und Infektionsprävention (2004) Anforderungen an die Hygiene bei der Reinigung und Desinfektion von Flächen. Bundesgesundheitsblatt 47:51–61
17. Kommission für Krankenhaushygiene und Infektionsprävention (2010) Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten. Bundesgesundheitsblatt 53:357–388
18. Kommission für Krankenhaushygiene und Infektionsprävention (2013) Risikocharakterisierung intensivmedizinisch behandelter Früh- und Neugeborener und Daten zur Ist-Situation in deutschen neonatologischen Intensivpflegestationen 2013. Fachliche Erläuterungen zu folgender Empfehlung: Praktische Umsetzung sowie krankenhaushygienische und infektionspräventive Konsequenzen des mikrobiellen Kolonisationsscreenings bei intensivmedizinisch behandelten Früh- und Neugeborenen. Ergänzende Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO). Supplement zum Epidemiologischen Bulletin Nr. 42. Robert Koch-Institut, Berlin
19. Kommission für Krankenhaushygiene und Infektionsprävention (2012) Ergänzende Empfehlung zur „Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g“ (2007). Epidemiol Bull 2:13–15
20. Kommission für Krankenhaushygiene und Infektionsprävention (2007) Empfehlung zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1.500 g. Bundesgesundheitsblatt 50:1265–1303
21. Robert Koch-Institut (2013) Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheitserregern mit speziellen Resistenzen und Multiresistenzen – Fortschreibung der Liste der gemäß § 4 Abs. 2 Nr. 2 Buchstabe b in Verbindung mit § 23 Abs. 4 IfSG zu erfassenden nosokomialen Infektionen und Krankheitserreger mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt 56:580–583
22. Kommission für Krankenhaushygiene und Infektionsprävention (2010) Die Kategorien der Richtlinie für Krankenhaushygiene und Infektionsprävention – Aktualisierung der Definitionen. Bundesgesundheitsblatt 53:754–756
23. van Belkum A, Verkaik NJ, de Vogel CP et al (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199:1820–1826
24. Becker K (2008) Virulenzfaktoren und molekulare Epidemiologie von Staphylococcus aureus – Renaissance eines alten Erregers? Kinder Jugendmed 8:73–82
25. Speziale P, Pietrocola G, Rindi S et al (2009) Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol 4:1337–1352
26. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16–34
27. Becker K, Friedrich AW, Lubritz G et al (2003) Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 41:1434–1439
28. Löffler B, Hussain M, Grundmeier M et al (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715
29. Tristan A, Ferry T, Durand G et al (2007) Virulence determinants in community and hospital methicillin-resistant Staphylococcus aureus. J Hosp Infect 65(Suppl 2):105–109
30. von Eiff CF, Peters G et al (2004) Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 49:157–162
31. Jappe U, Heuck D, Strommenger B et al (2008) Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 128:2655–2664
32. Monecke S, Slickers P, Ellington MJ et al (2007) High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 13:1157–1164
33. Schaumburg F, Köck R, Mellmann A et al (2012) Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol 50:3186–3192
34. Layer F, Werner G (2013) Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland – Update 2011/2012. Epidemiol Bull 21:187–193
35. Hanberger H, Walther S, Leone M et al (2011) Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 38:331–335
36. Cosgrove SE, Sakoulas G, Perencevich EN et al (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59
37. Whitby M, McLaws ML, Berry G (2001) Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175:264–267
38. Pujol M, Pena C, Pallares R et al (1996) Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100:509–516
39. Safdar N, Bradley EA (2008) The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 121:310–315
40. Coello R, Glynn JR, Gaspar C et al (1997) Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 37:39–46
41. Huang SS, Hinrichsen VL, Datta R et al (2011) Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PloS One 6:e24340
42. Datta R, Huang SS (2008) Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47:176–181
43. Stenehjem E, Rimland D (2013) MRSA nasal colonization burden and risk of MRSA infection. Am J Infect Control 41:405–410
44. Suetens C, Niclaes L, Jans B et al (2006) Methicillin-resistant Staphylococcus aureus colonization is associated with higher mortality in nursing home residents with impaired cognitive status. J Am Geriatr Soc 54:1854–1860
45. Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 333:281
46. Stamm AM, Long MN, Belcher B (1993) Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 21:70–74
47. Fukuta Y, Cunningham CA, Harris PL et al (2012) Identifying the risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection among patients colonized with MRSA on admission. Infect Control Hosp Epidemiol 33:1219–1225
48. de Kraker ME, Wolkewitz M, Davey PG et al (2011) Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 55:1598–1605
49. Engemann JJ, Carmeli Y, Cosgrove SE et al (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592–598
50. Köck R, Becker K, Cookson B et al (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15:19688
51. Macedo-Vinas M, De Angelis G, Rohner P et al (2013) Burden of methicillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect 84:132–137
52. Ott E (2010) Costs of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. J Hosp Infect 76:300–303
53. Herr CEW (2003) Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect Control Hosp Epidemiol 24:673–678
54. Harris SR, Feil EJ, Holden MT et al (2010) Evolution of MRSA during hospital transmission and intercontinental spread. Science 327:469–474
55. Nübel U, Dordel J, Kurt K et al (2010) A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog 6:e1000855
56. Köck R, Harlizius J, Bressan N et al (2009) Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis 28:1375–1382
57. Köck R, Brakensiek L, Mellmann A et al (2009) Cross-border comparison of the admission prevalence and clonal structure of methicillin-resistant Staphylococcus aureus. J Hosp Infect 71:320–326
58. Grabe C, Buckard R, El-Ansari T et al (2010) Flächendeckendes einmonatiges MRSA-Prävalenzscreening in Akut- und Rehakliniken in Siegen-Wittgenstein. Epidemiol Bull 18:163–166
59. Reich-Schupke S, Geis G, Reising M et al (2010) MRSA in dermatology – Prospective epidemiological study in employees and patients of a dermatological department of a university hospital. J Dtsch Dermatol Ges 8:607–613
60. Pohle M, Bär W, Bühling A et al (2012) Untersuchung der MRSA-Prävalenz in der Bevölkerung im Bereich des lokalen MRE-Netzwerkes Südbrandenburg. Epidemiol Bull 8:63–67
61. Herrmann M, Petit C, Dawson A et al (2013) Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PloS One 8:e73876
62. Chaberny IF, Bindseil A, Sohr D et al (2008) A point-prevalence study for MRSA in a German university hospital to identify patients at risk and to evaluate an established admission screening procedure. Infection 36:526–532
63. Popp W, Ross B, Raffenberg M et al (2012) Sektorenübergreifende MRSA-Eintagesprävalenzen – Erfahrungen aus Essen. Epidemiol Bull 27:249–251
64. Woltering R, Hoffmann G, Daniels-Haardt I et al (2008) Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany. Dtsch Med Wochenschr 133:999–1003
65. Kramer A, Ryll S, Wegner C et al (2011) One-day point prevalence of emerging bacterial pathogens in four secondary and five tertiary care German hospitals – results from a pilot study of the German Society for Hospital Hygiene (Deutsche Gesellschaft fur Krankenhaushygiene, DGKH). GMS Krankenhhyg Interdiszip 6:Doc20
66. Wegner C, Hübner N, Gleich S et al (2013) One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010. GMS Hyg Infect Control 8:Doc12
67. Chaberny IF, Behrends H-BM, Höpken EW et al (2011) Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus (MRSA) in 17 German hospitals: results of a point-prevalence study in the rural district Hannover. Int J Med Microbiol 301:1–126
68. Kresken M, Hafner D, Körber-Irrgang B (2013) Abschlussbericht – Teilprojekt H. Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem Hospitalbereich gegenüber Antibiotika. Bericht über die Ergebnisse einer multizentrischen Studie der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. Antiinfectives Intelligence, Rheinbach
69. Mielke M, Bölt U, Geffers C (2010) Basisdaten der stationären Krankenversorgung in Deutschland – nosokomiale Infektionen. Epidemiol Bull 36:359–368
70. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen. www.nrz-hygiene.de. Zugegriffen: April 2014
71. Geschäftsstelle Qualitätssicherung im Krankenhaus (GeQiK) (2014). http://www.geqik.de/index.php?id=943. Zugegriffen: April 2014
72. Robert Koch-Institut, SurvStat (Abfrage der Meldedaten nach Infektionsschutzgesetz (IfSG) über das Web). http://www3.rki.de/SurvStat/. Zugegriffen: April 2014
73. Friedrich A, Köck R, Jurke A et al (2011) MRSA in Rehakliniken in der EUREGIO. 9. Ulmer Symposium Krankenhausinfektionen Kongressband. mhp Verlag GmbH, Wiesbaden. S 61–62
74. Köck R, Winner K, Schaumburg F et al (2014) Admission prevalence and acquisition of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) in German rehabilitation centres. J Hosp Infect (im Druck)
75. Aizen E, Ljubuncic Z, Ljubuncic P et al (2007) Risk factors for methicillin-resistant Staphylococcus aureus colonization in a geriatric rehabilitation hospital. J Gerontol A Biol Sci Med Sci 62:1152–1156
76. Lauster F, Grosch I (2005) Die MRSA-Problematik in der Neurologischen Frührehabilitation. Hyg Med 30:332–335
77. Anguelov A, Giraud K, Akpabie A et al (2010) Predictive factors of acquired methicillin-resistant Staphylococcus aureus in a rehabilitation care unit. Méd Mal Infect 40:677–682
78. Girou E, Legrand P, Soing-Altrach S et al (2006) Association between hand hygiene compliance and methicillin-resistant Staphylococcus aureus prevalence in a French rehabilitation hospital. Infect Control Hosp Epidemiol 27:1128–1130
79. Bilavsky E, Lerman Y, Rabinovich A et al (2012) Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres – a prospective study. Clin Microbiol Infect 18:E164–E169
80. Pfingsten-Würzburg S, Pieper DH, Bautsch W et al (2011) Prevalence and molecular epidemiology of methicillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. J Hosp Infect 78:108–112
81. Gruber I, Heudorf U, Werner G et al (2013) Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care – prevalence and risk factors. Int J Med Microbiol 303:405–409
82. Heuck D, Witte W (2003) Methicillin-resistente Staphylococcus aureus (MRSA) in deutschen Alten- und Pflegeheimen – Zur Situation. Epidemiol Bull 19:145–148
83. von Baum HS, Svoboda D et al (2002) Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol 23:511–515
84. Neuhaus B, Bocter N, Braulke C et al (2002) Studie zum Vorkommen von Methicillin-resistenten Staphylococcus aureus in Alten- und Altenpflegeheimen in Nordrhein-Westfalen. Bundesgesundheitsblatt 45:894–904
85. Heudorf U, Gustav C, Mischler D et al (2014) Nosokomiale Infektionen, systemischer Antibiotikaeinsatz und multiresistente Erreger bei Bewohnern von Altenpflegeheimen – das Frankfurter HALT-plus MRE-Projekt. Bundesgesundheitsblatt 57:414–422
86. O’Sullivan NP, Keane CT (2000) Risk factors for colonization with methicillin-resistant Staphylococcus aureus among nursing home residents. J Hosp Infect 45:206–210
87. Cretnik TZ, Vovko P, Retelj M et al (2005) Prevalence and nosocomial spread of methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control Hosp Epidemiol 26:184–190
88. Denis O, Jans B, Deplano A et al (2009) Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother 64:1299–1306
89. Manzur A, Gavalda L, Ruiz de Gopegui E et al (2008) Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clin Microbiol Infect 14:867–872
90. Brugnaro P, Fedeli U, Pellizzer G et al (2009) Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection 37:216–221
91. Barr B, Wilcox MH, Brady A et al (2007) Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infect Control Hosp Epidemiol 28:853–859
92. Baldwin NS, Gilpin DF, Hughes CM et al (2009) Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc 57:620–626
93. Mossong J, Gelhausen E, Decruyenaere F et al (2013) Prevalence, risk factors and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) colonization in residents of long-term care facilities in Luxembourg. Epidemiol Infect 141:1199–1206
94. Greenland K, Rijnders MI, Mulders M et al (2011) Low prevalence of methicillin-resistant Staphylococcus aureus in Dutch nursing homes. J Am Geriatr Soc 59:768–769
95. Andersson H, Lindholm C, Iversen A et al (2012) Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis 44:641–649
96. Trick WE, Weinstein RA, DeMarais PL et al (2001) Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 49:270–276
97. O’Fallon E, Pop-Vicas A, D’Agata E (2009) The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci 64:138–141
98. Pop-Vicas A, Mitchell SL, Kandel R et al (2008) Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 56:1276–1280
99. Reynolds C, Quan V, Kim D et al (2011) Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California. Infect Control Hosp Epidemiol 32:91–93
100. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136:834–844
101. Stone ND, Lewis DR, Lowery HK et al (2008) Importance of bacterial burden among methicillin-resistant Staphylococcus aureus carriers in a long-term care facility. Infect Control Hosp Epidemiol 29:143–148
102. Suetens C, Niclaes L, Jans B et al (2007) Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age Ageing 36:327–330
103. Daeschlein G, Assadian O, Rangous I et al (2006) Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect 63:216–220
104. Mody L, Kauffman CA, Donabedian S et al (2008) Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis 46:1368–1373
105. Eveillard M, Charru P, Rufat P et al (2008) Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing 37:294–299
106. Dancer SJ (2001) The problem with cephalosporins. J Antimicrob Chemother 48:463–478
107. Flannery EL, Wang L, Zollner S et al (2011) Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis 53:1215–1222
108. Dasenbrook EC (2011) Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis. Curr Opin Pulm Med 17:437–441
109. Simon A, Schmitt-Grohe S, Erdmann U et al (2012) Anforderungen an die Hygiene bei der medizinischen Versorgung von Patienten mit Cystischer Fibrose (Mukoviszidose) – unter Beteiligung der DGPI, der Arbeitsgemeinschaft Mukoviszidose der GPP sowie der DGKJ, 1. Aufl. mhp, Homburg
110. Dawson A, Mischler D, Petit C et al (2012) Prevalence of methicillin-resistant Staphylococcus aureus in end stage renal failure patients in Saarland and Hessen, Abstract. Intern J Med Microbiol 302:87
111. Lederer SR, Riedelsdorf G, Schiffl H (2007) Nasal carriage of methicillin-resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 12:284–288
112. Curtin J, Dalziel C (2010) Beat those bugs! Implementing contact precautions in community dialysis units for closer-to-home care. Can J Infect Control 25:9–16
113. Marchaim D, Lazarovitch Z, Efrati S et al (2005) Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units. Nephron Clin Pract 101:c58–c64
114. Saxena AK, Panhotra BR, Al-hafiz AA et al (2012) Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers. Saudi J Kidney Dis Transpl 23:743–754
115. Lu PL, Tsai JC, Chiu YW et al (2008) Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 23:1659–1665
116. Lai CF, Liao CH, Pai MF et al (2011) Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 6:167–174
117. Kang YC, Tai WC, Yu CC et al (2012) Methicillin-resistant Staphylococcus aureus nasal carriage among patients receiving hemodialysis in Taiwan: prevalence rate, molecular characterization and decolonization. BMC Infect Dis 12:284
118. Koseoglu O, Sayin Kutlu S, Cevahir N (2012) Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization among outpatients undergoing hemodialysis treatment. Mikrobiyol Bul 46:106–112
119. Hadley AC, Karchmer TB, Russell GB et al (2007) The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol 27:352–359
120. Pop-Vicas A, Strom J, Stanley K et al (2008) Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 3:752–758
121. Johnson LB, Jose J, Yousif F et al (2009) Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 30:4–8
122. Patel G, Jenkins SG, Mediavilla JR et al (2011) Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus among patients in an ambulatory hemodialysis center. Infect Control Hosp Epidemiol 32:881–888
123. Köck R, Werner P, Friedrich A et al (2012) Characteristics of Staphylococcus aureus nasal carriage, resistance patterns and genetic lineages in healthy german adults. In: 52nd interscience conference on antimicrobial agents and chemotherapy, San Francisco, USA. American Society for Microbiology, Washington
124. David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687
125. Witte W, Strommenger B, Cuny C et al (2007) Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 60:1258–1263
126. Köck R, Mellmann A, Schaumburg F et al (2011) The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany. Dtsch Ärztebl Int 108:761–767
127. Thurman AR, Anca Y, White CA et al (2010) Post-cesarean delivery infectious morbidity: focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus. Am J Infect Control 38:612–616
128. Stafford I, Hernandez J, Laibl V et al (2008) Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol 112:533–537
129. Beigi RH, Bunge K, Song Y et al (2009) Epidemiologic and economic effect of methicillin-resistant Staphylococcus aureus in obstetrics. Obstet Gynecol 113:983–991
130. Branch-Elliman W, Golen TH, Gold HS et al (2012) Risk factors for Staphylococcus aureus postpartum breast abscess. Clin Infect Dis 54:71–77
131. Laibl VR, Sheffield JS, Roberts S et al (2005) Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol 106:461–465
132. Gray J, Patwardhan SC, Martin W (2010) Methicillin-resistant Staphylococcus aureus screening in obstetrics: a review. J Hosp Infect 75:89–92
133. Lucet JC, Regnier B (2010) Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? Clin Infect Dis 51:585–590
134. Tübbicke A, Hübner C, Kramer A et al (2012) Transmission rates, screening methods and costs of MRSA – a systematic literature review related to the prevalence in Germany. Eur J Clin Microbiol Infect Dis 31:2497–2511
135. Patel RI, Kaufman HK (2011) Nasopharyngeal carriage of methicillin-resistant Staphylococcus aureus: incidence and outcomes in pregnant women. J Am Osteopath Assoc 111:389–395
136. Andrews WW, Schelonka R, Waites K et al (2008) Genital tract methicillin-resistant Staphylococcus aureus: risk of vertical transmission in pregnant women. Obstet Gynecol 111:113–118
137. Chen KT, Huard RC, Della-Latta P et al (2006) Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 108:482–487
138. Top KA, Huard RC, Fox Z et al (2010) Trends in methicillin-resistant Staphylococcus aureus anovaginal colonization in pregnant women in 2005 versus 2009. J Clin Microbiol 48:3675–3680
139. Lazenby GB, Soper DE, Beardsley W et al (2012) Methicillin-resistant Staphylococcus aureus colonization among women admitted for preterm delivery. Am J Obstet Gynecol 206(329):e321–e325
140. Creech CB, Litzner B, Talbot TR et al (2010) Frequency of detection of methicillin-resistant Staphylococcus aureus from rectovaginal swabs in pregnant women. Am J Infect Control 38:72–74
141. Huang YC, Chao AS, Chang SD et al (2009) Association of Staphylococcus aureus colonization in parturient mothers and their babies. Pediatr Infect Dis J 28:742–744
142. Tomlinson MW, Schmidt NM, Rourke JW Jr et al (2011) Rectovaginal Staphylococcus aureus colonization: is it a neonatal threat? Am J Perinatol 28:673–676
143. Jimenez-Truque N, Tedeschi S, Saye EJ et al (2012) Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 129:e1252–e1259
144. Ghanim N, Alchyib O, Morrish D et al (2011) Maternal-neonatal outcome with Staphylococcus aureus rectovaginal colonization. J Reprod Med 56:421–424
145. Pinter DM, Mandel J, Hulten KG et al (2009) Maternal-infant perinatal transmission of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Am J Perinatol 26:145–151
146. Reusch M, Ghosh P, Ham C et al (2008) Prevalence of MRSA colonization in peripartum mothers and their newborn infants. Scand J Infect Dis 40:667–671
147. Albrich WC, Harbarth S (2008) Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 8:289–301
148. Dietze B, Rath A, Rüden H (1996) Kann durch die Einhaltung strikter Hygienemaßnahmen und umfassende Personaluntersuchungen eine MRSA-Epidemie beendet werden? Hyg Med 21:412–423
149. Kaminski A, Kammler J, Wick M et al (2007) Transmission of methicillin-resistant Staphylococcus aureus among hospital staff in a German trauma centre: a problem without a current solution? J Bone Joint Surg Br 89:642–645
150. Kampf G, Adena S, Rüden H et al (2003) Inducibility and potential role of mecA-gene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infections. J Hosp Infect 54:124–129
151. Witte W, Mielke M, Ammon A et al (2005) Fachtagung der AG Nosokomiale Infektionen am RKI zur Intensivierung der Umsetzung von Präventionsstrategien bei MRSA. Epidemiol Bull 5:31–38
152. Joos AK (2009) MRSA-Personalscreening in einer Chirurgischen Universitätsklinik. Hyg Med 34:183–187
153. Saßmannshausen R (2012) Prävalenz und Sanierung von Methicillin-resistenten Staphylococcus aureus (MRSA) bei Klinikpersonal im deutschen Teil des EUREGIO-Gebietes. Westfälische Wilhelms-Universität Münster, Münster
154. Bundesinstitut für Risikobewertung (BfR) (2009) Molekularbiologische Charakterisierung und Quantifizierung von Methicillin-resistenten Staphylococcus aureus (MRSA) aus landwirtschaftlichen Nutztieren und vom Tier stammenden Lebensmitteln, Vorläufiger Abschlussbericht (Förderkennzeichen 2808HS032). BfR, Berlin
155. Köck R, Loth B, Koksal M et al (2012) Persistence of nasal colonization with livestock-associated methicillin-resistant Staphylococcus aureus in pig farmers after holidays from pig exposure. Appl Environ Microbiol 78:4046–4047
156. Cuny C, Nathaus R, Layer F et al (2009) Nasal colonization of humans with methicillin-resistant Staphylococcus aureus (MRSA) CC398 with and without exposure to pigs. PloS One 4:e6800
157. Bisdorff B, Scholholter JL, Claussen K et al (2012) MRSA-ST398 in livestock farmers and neighbouring residents in a rural area in Germany. Epidemiol Infect 140:1800–1808
158. Cuny C, Friedrich A, Kozytska S et al (2010) Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species. Int J Med Microbiol 300:109–117
159. Witte W, Strommenger B, Stanek C et al (2007) Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis 13:255–258
160. Köck R (2013) Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PloS One 8:e55040
161. Walther B, Wieler LH, Friedrich AW et al (2008) Methicillin-resistant Staphylococcus aureus (MRSA) isolated from small and exotic animals at a university hospital during routine microbiological examinations. Vet Microbiol 127:171–178
162. Nienhoff U (2009) Transmission of methicillin-resistant Staphylococcus aureus strains between humans and dogs: two case reports. J Antimicrob Chemother 64:660–662
163. Wagenvoort JH, De Brauwer EI, Sijstermans ML et al (2005) Risk of re-introduction of methicillin-resistant Staphylococcus aureus into the hospital by intrafamilial spread from and to healthcare workers. J Hosp Infect 59:67–68
164. Portigliatti Barbos MM, Pecoraro S et al (2010) Decolonization of orthopedic surgical team S. aureus carriers: impact on surgical-site infections. J Orthop Traumatol 11:47–49
165. Gurieva TV, Bootsma MC, Bonten MJ (2012) Decolonization of patients and health care workers to control nosocomial spread of methicillin-resistant Staphylococcus aureus: a simulation study. BMC Infect Dis 12:302
166. Witte W, Cuny C, Braulke C et al (1997) Widespread dissemination of epidemic MRSA in German hospitals. Euro Surveill 2:25–28
167. Laine J, Huttunen R, Vuento R et al (2013) Methicillin-resistant Staphylococcus aureus epidemic restricted to one health district in Finland: a population-based descriptive study in Pirkanmaa, Finland, years 2001–2011. Scand J Infect Dis 45:45–53
168. Sexton T, Clarke P, O’Neill E et al (2006) Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect 62:187–194
169. Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130
170. Dancer SJ, White LF, Lamb J et al (2009) Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 7:28
171. Boyce JM (2007) Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 65(Suppl 2):50–54
172. von Eiff CB, Machka K et al (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344:11–16
173. Hübner NO, Thanheiser M (2013) Infection prevention in surgical and endoscopic procedures. Gastrointest Med Surg 29:166–173
174. Pittet D, Hugonnet S, Harbarth S et al (2000) Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356:1307–1312
175. Lai KK, Fontecchio S, Melvin Z et al (2006) Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 27:1018–1024
176. Sherertz RJ, Reagan DR, Hampton KD et al (1996) A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 124:539–547
177. Bassetti S, Bischoff WE, Walter M et al (2005) Dispersal of Staphylococcus aureus into the air associated with a rhinovirus infection. Infect Control Hosp Epidemiol 26:196–203
178. Sherertz RJ, Bassetti S, Bassetti-Wyss B (2001) „Cloud“ health-care workers. Emerg Infect Dis 7:241–244
179. Subirana M, Sola I, Benito S (2007) Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database Syst Rev (4):CD004581
180. Ricard JD, Eveillard M, Martin Y et al (2011) Influence of tracheal suctioning systems on health care workers’ gloves and equipment contamination: a comparison of closed and open systems. Am J Infect Control 39:605–607
181. Shiomori T, Miyamoto H, Makishima K et al (2002) Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect 50:30–35
182. Eames I, Tang JW, Li Y et al (2009) Airborne transmission of disease in hospitals. J R Soc Interface 6(Suppl 6):S697–S702
183. Berman DS, Schaefler S, Simberkoff MS et al (1986) Tourniquets and nosocomial methicillin-resistant Staphylococcus aureus infections. N Engl J Med 315:514–515
184. Cohen HA, Amir J, Matalon A et al (1997) Stethoscopes and otoscopes – a potential vector of infection? Fam Pract 14:446–449
185. Bures S, Fishbain JT, Uyehara CF et al (2000) Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 28:465–471
186. Dancer SJ (2008) Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 8:101–113
187. Treakle AM, Thom KA, Furuno JP et al (2009) Bacterial contamination of health care workers’ white coats. Am J Infect Control 37:101–105
188. Hübner NO, Flessa S, Haak J et al (2011) Can the Hazard Assessment and Critical Control Points (HACCP) system be used to design process-based hygiene concepts? GMS Krankenhhyg Interdiszip 6:Doc24
189. Ajao AO, Harris AD, Roghmann MC et al (2011) Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol 32:481–489
190. Colbeck JC (1960) Environmental aspects of staphylococcal infections acquired in hospitals. I. The hospital environment – its place in the hospital Staphylococcus infections problem. Am J Public Health Nations Health 50:468–473
191. Wang J, Wang M, Huang Y et al (2011) Colonization pressure adjusted by degree of environmental contamination: a better indicator for predicting methicillin-resistant Staphylococcus aureus acquisition. Am J Infect Control 39:763–769
192. Moore C, Dhaliwal J, Tong A et al (2008) Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acute-care hospital. Infect Control Hosp Epidemiol 29:600–606
193. White A (1961) Quantitative studies of nasal carriers of staphylococci among hospitalized patients. J Clin Invest 40:23–30
194. Vonberg RP, Stamm-Balderjahn S, Hansen S et al (2006) How often do asymptomatic healthcare workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation. Infect Control Hosp Epidemiol 27:1123–1127
195. Watanabe H, Masaki H, Asoh N et al (2000) Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract. J Clin Microbiol 38:3867–3869
196. Cepeda JA, Whitehouse T, Cooper B et al (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365:295–304
197. Cataldo MA, Taglietti F, Petrosillo N (2010) Methicillin-resistant Staphylococcus aureus: a community health threat. Postgrad Med 122:16–23
198. Gastmeier P (2010) Healthcare-associated versus community-acquired infections: a new challenge for science and society. Int J Med Microbiol 300:342–345
199. Stone ND, Lewis DR, Johnson TM II et al (2012) Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of veterans affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition. Infect Control Hosp Epidemiol 33:551–557
200. Rosenthal VD, Maki DG, Jamulitrat S et al (2010) International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003–2008, issued June 2009. Am J Infect Control 38:95–104
201. Robotham JV, Scarff CA, Jenkins DR et al (2007) Methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and the community: model predictions based on the UK situation. J Hosp Infect 65(Suppl 2):93–99
202. Kajita E, Okano JT, Bodine EN et al (2007) Modelling an outbreak of an emerging pathogen. Nat Rev Microbiol 5:700–709
203. Cooper BS, Kypraios T, Batra R et al (2012) Quantifying type-specific reproduction numbers for nosocomial pathogens: evidence for heightened transmission of an Asian sequence type 239 MRSA clone. PLoS Comput Biol 8:e1002454
204. Cooper BS, Medley GF, Stone SP et al (2004) Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A 101:10223–10228
205. Bootsma MC, Wassenberg MW, Trapman P et al (2011) The nosocomial transmission rate of animal-associated ST398 methicillin-resistant Staphylococcus aureus. J R Soc Interface 8:578–584
206. Gurieva T, Bootsma MC, Bonten MJ (2012) Successful veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections revisited. Clin Infect Dis 54:1618–1620
207. Esveld MI, de Boer AS, Notenboom AJ et al (1999) Secondary infection with methicillin-resistant Staphylococcus aureus in Dutch hospitals (July 1997–June 1996). Ned Tijdschr Geneeskd 143:205–208
208. Martin U, Sonntag AK, Neuhaus B et al (2004) Surface disinfection in nursing homes – what is really happening? Study of control success in three Duisburg nursing homes. Gesundheitswesen 66:682–687
209. Hughes C, Smith M, Tunney M et al (2011) Infection control strategies for preventing the transmission of methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people. Cochrane Database Syst Rev (1):CD006354
210. Baldwin NS, Gilpin DF, Tunney MM et al (2010) Cluster randomised controlled trial of an infection control education and training intervention programme focusing on methicillin-resistant Staphylococcus aureus in nursing homes for older people. J Hosp Infect 76:36–41
211. Horner C, Wilcox M, Barr B et al (2012) The longitudinal prevalence of MRSA in care home residents and the effectiveness of improving infection prevention knowledge and practice on colonisation using a stepped wedge study design. BMJ Open 2:e000423
212. Brown R, Minnon J, Schneider S et al (2010) Prevalence of methicillin-resistant Staphylococcus aureus in ambulances in southern Maine. Prehosp Emerg Care 14:176–181
213. Roline CE, Crumpecker C, Dunn TM (2007) Can methicillin-resistant Staphylococcus aureus be found in an ambulance fleet? Prehosp Emerg Care 11:241–244
214. Kober P, Labes H, Möller H et al (2000) Mikrobiologische Kontamination und Hygienemaßnahmen in Rettungswagen. Hyg Med 25:296–302
215. Fischer D, Veldman A, Schäfer V et al (2004) Bacterial colonization of patients undergoing international air transport: a prospective epidemiologic study. J Travel Med 11:44–48
216. Ro YS, Shin SD, Noh H et al (2012) Prevalence of positive carriage of tuberculosis, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant Enterococci in patients transported by ambulance: a single center observational study. J Prev Med Public Health 45:174–180
217. Nigam Y, Cutter J (2003) A preliminary investigation into bacterial contamination of Welsh emergency ambulances. Emerg Med J 20:479–482
218. Noh H, Shin SD, Kim NJ et al (2011) Risk stratification-based surveillance of bacterial contamination in metropolitan ambulances. J Korean Med Sci 26:124–130
219. Groß R (2009) Analyse des Hygienestatus und des Personalschutzes im deutschen Rettungsdienst und Krankentransport. Dissertation. Med. Fakultät, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald
220. Wildermuth S, Stahl W, Dirks B et al. (2012) Die Ulmer Secure Studie: Keimbelastung im Rettungsdienst. Vortrag DGKG, 2012. HygMed, 37-Supplement
221. Eibicht SJ, Vogel U (2011) Methicillin-resistant Staphylococcus aureus (MRSA) contamination of ambulance cars after short term transport of MRSA-colonised patients is restricted to the stretcher. J Hosp Infect 78:221–225
222. Erk G-O, Brandt C, Heudorf U (2013) Mikrobielle Belastung und multiresistente Erreger im qualifizierten und nichtqualifizierten Krankentransport. Hyg Med 38:23–29
223. Davis MF, Iverson SA, Baron P et al (2012) Household transmission of methicillin-resistant Staphylococcus aureus and other staphylococci. Lancet Infect Dis 12:703–716
224. Mollema FP, Richardus JH, Behrendt M et al (2010) Transmission of methicillin-resistant Staphylococcus aureus to household contacts. J Clin Microbiol 48:202–207
225. Johansson PJ, Gustafsson EB, Ringberg H (2007) High prevalence of MRSA in household contacts. Scand J Infect Dis 39:764–768
226. Niniou I, Vourli S, Lebessi E et al (2008) Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece. Eur J Clin Microbiol Infect Dis 27:831–837
227. Bundesverband für Tiergesundheit e.V. (BfT) (2013) Tierbestand in Deutschland 2011–2012 in Mio. Tiergesundheit Blickpunkt 72:3
228. van Cleef BA, Graveland H, Haenen AP et al (2011) Persistence of livestock-associated methicillin-resistant Staphylococcus aureus in field workers after short-term occupational exposure to pigs and veal calves. J Clin Microbiol 49:1030–1033
229. Graveland H, Wagenaar JA, Heesterbeek H et al (2010) Methicillin-resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PloS One 5:e10990
230. Alt K, Fetsch A, Schroeter A et al (2011) Factors associated with the occurrence of MRSA CC398 in herds of fattening pigs in Germany. BMC Vet Res 7:69
231. Broens EM, Graat EA, Van der Wolf PJ et al (2011) Prevalence and risk factor analysis of livestock associated MRSA-positive pig herds in The Netherlands. Prev Vet Med 102:41–49
232. Hartung M, Käsbohrer A (2013) Erreger von Zoonosen in Deutschland im Jahr 2011.
233. Hartung M, Käsbohrer A (2011) Erreger von Zoonosen in Deutschland im Jahr 2009.
234. de Boer E, Zwartkruis-Nahuis JT, Wit B et al (2009) Prevalence of methicillin-resistant Staphylococcus aureus in meat. Int J Food Microbiol 134:52–56
235. Pu S, Han F, Ge B (2009) Isolation and characterization of methicillin-resistant Staphylococcus aureus strains from Louisiana retail meats. Appl Environ Microbiol 75:265–267
236. Weese JS, Reid-Smith R, Rousseau J et al (2010) Methicillin-resistant Staphylococcus aureus (MRSA) contamination of retail pork. Can Vet J 51:749–752
237. Cuny C, Layer F, Witte W (2011) Staphylococcus aureus and MRSA in thawing liquid of broiler chicken cacasses and their relation to clonal lineages from humans (Abstract ZOV01). Intern J Med Microbiol S1:117
238. Richter A, Sting R, Popp C et al (2012) Prevalence of types of methicillin-resistant Staphylococcus aureus in turkey flocks and personnel attending the animals. Epidemiol Infect 140:2223–2232
239. Schulz J, Friese A, Klees S et al (2012) Longitudinal study of the contamination of air and of soil surfaces in the vicinity of pig barns by livestock-associated methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol 78:5666–5671
240. Strommenger B, Kehrenberg C, Kettlitz C et al (2006) Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother 57:461–465
241. Walther B, Wieler L, Friedrich A et al (2009) Staphylococcus aureus and MRSA colonization rates among personnels and dogs in a small animal hospital: association with nosocomial infections. Berl Munch Tierarztl Wochenschr 122:178–185
242. Walther B, Hermes J, Cuny C et al (2012) Sharing more than friendship – nasal colonization with coagulase-positive staphylococci (CPS) and co-habitation aspects of dogs and their owners. PloS One 7:e35197
243. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO), Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2012) Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten. Bundesgesundheitsblatt 55:1244–1310
244. Kommision für Krankenhaushygiene und Infektionsprävention (2007) Anforderungen der Krankenhaushygiene und des Arbeitsschutzes an die Hygienebekleidung und persönliche Schutzausrüstung. Epidemiol Bull 1:3–4
245. Eveillard M, Lancien E, Barnaud G et al (2005) Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure. J Hosp Infect 59:254–258
246. Lucet JC, Paoletti X, Lolom I et al (2005) Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 31:1051–1057
247. Ellingson K, Muder RR, Jain R et al (2011) Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infect Control Hosp Epidemiol 32:1–8
248. Holzmann-Pazgal G, Monney C, Davis K et al (2011) Active surveillance culturing impacts methicillin-resistant Staphylococcus aureus acquisition in a pediatric intensive care unit. Pediatr Crit Care Med 12:e171–e175
249. Reilly JS, Stewart S, Christie P et al (2012) Universal screening for methicillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. J Hosp Infect 80:31–35
250. Souweine B, Traore O, Aublet-Cuvelier B et al (2000) Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 45:107–116
251. Huang SS, Yokoe DS, Hinrichsen VL et al (2006) Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 43:971–978
252. Shitrit P, Gottesman BS, Katzir M et al (2006) Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol 27:1004–1008
253. Pan A, Carnevale G, Catenazzi P et al (2005) Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 26:127–133
254. Tomic V, Svetina Sorli P, Trinkaus D et al (2004) Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med 164:2038–2043
255. Wernitz MH, Swidsinski S, Weist K et al (2005) Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 11:457–465
256. West TE, Guerry C, Hiott M et al (2006) Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 27:233–238
257. Awad SS, Palacio CH, Subramanian A et al (2009) Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections. Am J Surg 198:607–610
258. Jog S, Cunningham R, Cooper S et al (2008) Impact of preoperative screening for methicillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 69:124–130
259. Keshtgar MR, Khalili A, Coen PG et al (2008) Impact of rapid molecular screening for methicillin-resistant Staphylococcus aureus in surgical wards. Br J Surg 95:381–386
260. Robicsek A, Beaumont JL, Paule SM et al (2008) Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148:409–418
261. Martinez-Capolino C, Reyes K, Johnson L et al (2010) Impact of active surveillance on methicillin-resistant Staphylococcus aureus transmission and hospital resource utilisation. J Hosp Infect 74:232–237
262. Chowers MY, Paitan Y, Gottesman BS et al (2009) Hospital-wide methicillin-resistant Staphylococcus aureus control program: a 5-year follow-up. Infect Control Hosp Epidemiol 30:778–781
263. Pofahl WE, Goettler CE, Ramsey KM et al (2009) Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg 208:981–988
264. Harbarth S, Masuet-Aumatell C, Schrenzel J et al (2006) Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care (London England) 10:R25
265. Troche G, Joly LM, Guibert M et al (2005) Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 26:161–165
266. Gould IM, MacKenzie FM, MacLennan G et al (2007) Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 29:536–543
267. Clancy M, Graepler A, Wilson M et al (2006) Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 27:1009–1017
268. Thompson DS, Workman R, Strutt M (2009) Decline in the rates of methicillin-resistant Staphylococcus aureus acquisition and bacteraemia in a general intensive care unit between 1996 and 2008. J Hosp Infect 71:314–319
269. Rodriguez-Bano J, Garcia L, Ramirez E et al (2010) Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol 31:786–795
270. Chaberny I, Schwab F, Ziesing S et al (2008) Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother 62:1422–1429
271. Tacconelli E, De Angelis G, de Waure C et al (2009) Rapid screening tests for methicillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 9:546–554
272. Bootsma MC, Diekmann O, Bonten MJ (2006) Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 103:5620–5625
273. Raboud J, Saskin R, Simor A et al (2005) Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infect Control Hosp Epidemiol 26:607–615
274. Harbarth S, Fankhauser C, Schrenzel J et al (2008) Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299:1149–1157
275. Kurup A, Chlebicka N, Tan KY et al (2010) Active surveillance testing and decontamination strategies in intensive care units to reduce methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 38:361–367
276. Leonhardt KK, Yakusheva O, Phelan D et al (2011) Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol 32:797–803
277. Wang JT, Lauderdale TL, Lee WS et al (2010) Impact of active surveillance and contact isolation on transmission of methicillin-resistant Staphylococcus aureus in intensive care units in an area with high prevalence. J Formos Med Assoc 109:258–268
278. Warren DK, Guth RM, Coopersmith CM et al (2007) Impact of a methicillin-resistant Staphylococcus aureus active surveillance program on contact precaution utilization in a surgical intensive care unit. Crit Care Med 35:430–434
279. Huskins WC, Huckabee CM, O’Grady NP et al (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407–1418
280. Cunningham R, Jenks P, Northwood J et al (2007) Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 65:24–28
281. Noorani HZ, Adams E, Glick S et al (2013) Screening for methicillin-resistant Staphylococcus aureus (MRSA): future research needs: identification of future research needs from comparative effectiveness, Review No. 102. Agency for Healthcare Research and Quality, Rockville (MD)
282. Aldeyab MA, Kearney MP, Hughes CM et al (2009) Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial methicillin-resistant Staphylococcus aureus? J Hosp Infect 71:22–28
283. Camus C, Bellissant E, Legras A et al (2011) Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patients. Infect Control Hosp Epidemiol 32:1064–1072
284. Jeyaratnam D, Whitty CJ, Phillips K et al (2008) Impact of rapid screening tests on acquisition of methicillin-resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 336:927–930
285. Hardy K, Price C, Szczepura A et al (2010) Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 16:333–339
286. Kohlenberg ASF, Behnke M, Gastmeier P (2011) Screening and control of MRSA in 186 intensive care units: different situations and individual solutions. Crit Care Med 15:R285
287. Vos MC, Behrendt MD, Melles DC et al (2009) 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 30:977–984
288. Salgado CD, Farr BM (2006) What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 27:116–121
289. Tübbicke A, Hübner C, Hübner NO et al (2012) Cost comparison of MRSA screening and management – a decision tree analysis. BMC Health Serv Res 12:438
290. Mertz D, Frei R, Jaussi B et al (2007) Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 45:475–477
291. Nilsson P, Ripa T (2006) Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol 44:3334–3339
292. Mertz D, Frei R, Periat N et al (2009) Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 169:172–178
293. Harbarth S, Schrenzel J, Renzi G et al (2007) Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol 45:1072–1073
294. Marshall C, Spelman D (2007) Re: is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol 45:3855
295. Heng Sim BL,McBryde, Street AC et al (2013) Multiple site surveillance cultures as a predictor of methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol 34:818–824
296. Bitterman Y, Laor A, Itzhaki S et al (2010) Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization. Eur J Clin Microbiol Infect Dis 29:391–397
297. McKinnell JA, Huang SS, Eells SJ et al (2013) Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34:161–170
298. Daeschlein G, Assadian O, Daxboeck F et al (2006) Multiplex PCR-ELISA for direct detection of MRSA in nasal swabs advantageous for rapid identification of non-MRSA carriers. Eur J Clin Microbiol Infect Dis 25:328–330
299. Holfelder M, Eigner U, Turnwald AM et al (2006) Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay. Clin Microbiol Infect 12:1163–1167
300. Becker K, Berner R, Eckmann C et al (2013) Infektionen der Haut und der subkutanen Weichgewebe. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. MIQ 06b. Elsevier, München
301. Forster AJ, Oake N, Roth V et al (2013) Patient-level factors associated with methicillin-resistant Staphylococcus aureus carriage at hospital admission: a systematic review. Am J Infect Control 41:214–220
302. Köck R (2013) Zum Aufwand von MRSA-Screeninguntersuchungen in deutschen Krankenhäusern. Epidemiol Bull 5:41–44
303. Chi CY, Wong WW, Fung CP et al (2004) Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 37:16–23
304. Bode LG, Kluytmans JA, Wertheim HF et al (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362:9–17
305. Patel M, Weinheimer JD, Waites KB et al (2008) Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a veterans affairs medical denter. Infect Control Hosp Epidemiol 29:503–509
306. Schmid H, Romanos A, Schiffl H et al (2013) Persistent nasal methicillin-resistant Staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcome. BMC Nephrol 14:93
307. Carnicer-Pont D, Bailey KA, Mason BW et al (2006) Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study. Epidemiol Infect 134:1167–1173
308. Yoon YK, Kim JY, Park DW et al (2010) Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65:1015–1018
309. Fowler JVG, Justice A, Moore C et al (2005) Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40:695–703
310. Kato N, Tanaka J, Mori A et al (2003) The risk of persistent carriage of methicillin-resistant Staphylococcus aureus in hematopoietic stem cell transplantation. Ann Hematol 82:310–312
311. Nguyen MH, Kauffman CA, Goodman RP et al (1999) Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 130:221–225
312. Bessesen MT, Lopez K, Guerin K et al (2013) Comparison of control strategies for methicillin-resistant Staphylococcus aureus. Am J Infect Control 42:91
313. Bracco D, Dubois MJ, Bouali R et al (2007) Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 33:836–840
314. Cheng VC, Tai JW, Chan WM et al (2010) Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit. BMC Infect Dis 10:263
315. Curran ET, Hamilton K, Monaghan A et al (2006) Use of a temporary cohort ward as part of an intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus in a vascular surgery ward. J Hosp Infect 63:374–379
316. Fitzpatrick F, Murphy OM, Brady A et al (2000) A purpose built MRSA cohort unit. J Hosp Infect 46:271–279
317. Gagne D, Bedard G, Maziade PJ (2010) Systematic patients’ hand disinfection: impact on methicillin-resistant Staphylococcus aureus infection rates in a community hospital. J Hosp Infect 75:269–272
318. Gastmeier P, Schwab F, Geffers C et al (2004) To isolate or not to isolate? Analysis of data from the German nosocomial infection surveillance system regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 25:109–113
319. Gilomen S, Ruef C, Held L et al. (2011) Successful control of methicillin-resistant Staphylococcus aureus outbreak at a university department of dermatology. J Eur Acad Dermatol Venereol 25:441–446
320. Gilroy SA, Miller Stahl B, Noonan C et al (2009) Reduction of hospital-acquired methicillin-resistant Staphylococcus aureus infection by cohorting patients in a dedicated unit. Infect Control Hosp Epidemiol 30:203–205
321. Gregory ML, Eichenwald EC, Puopolo KM (2009) Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 123:e790–e796
322. Jain R, Kralovic SM, Evans ME et al (2011) Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364:1419–1430
323. Marshall C, Richards M, McBryde E (2013) Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PloS One 8:e58112
324. Mastoraki A, Kriaras I, Douka E et al (2008) Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery. Interact Cardiovasc Thorac Surg 7:452–456
325. Safdar N, Marx J, Meyer NA et al (2006) Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am J Infect Control 34:476–483
326. Teltsch DY, Hanley J, Loo V et al (2011) Infection acquisition following intensive care unit room privatization. Arch Intern Med 171:32–38
327. Trautmann M, Pollitt A, Loh U et al (2007) Implementation of an intensified infection control program to reduce MRSA transmissions in a German tertiary care hospital. Am J Infect Control 35:643–649
328. Landelle C, Pagani L, Harbarth S (2013) Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence 4:163–171
329. Lee AS, Cooper BS, Malhotra-Kumar S et al (2013) Comparison of strategies to reduce methicillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open 3:e003126
330. Fazal BA, Telzak EE, Blum S et al (1996) Trends in the prevalence of methicillin-resistant Staphylococcus aureus associated with discontinuation of an isolation policy. Infect Control Hosp Epidemiol 17:372–374
331. Lecornet E, Robert J, Jacqueminet S et al (2007) Preemptive isolation to prevent methicillin-resistant Staphylococcus aureus cross-transmission in diabetic foot. Diabetes Care 30:2341–2342
332. Kalenic S, Pal MP, Palcevski VV et al (2010) Guidelines for prevention, control and treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA): changes and updates of chapter 7.0: treatment of patients with MRSA infection. Lijec Vjesn 132:340–344
333. Burke JP (2003) Infection control – a problem for patient safety. N Engl J Med 348:651–656
334. Stelfox HT (2003) Safety of patients isolated for infection control. JAMA 290:1899–1905
335. Morgan DJ, Diekema DJ, Sepkowitz K et al (2009) Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 37:85–93
336. Masse V, Valiquette L, Boukhoudmi S et al (2013) Impact of methicillin-resistant Staphylococcus aureus contact isolation units on medical care. PloS One 8:e57057
337. Hartmann C (2006) How do patients experience isolation due to an infection or colonisation with MRSA? Pflege Z 59(10):suppl 2–8
338. Gasink LB, Singer K, Fishman NO et al (2008) Contact isolation for infection control in hospitalized patients: is patient satisfaction affected? Infect Control Hosp Epidemiol 29:275–278
339. Safdar N, Maki DG (2004) Quality of care and satisfaction among patients isolated for infection control. JAMA 291:420–422
340. Cohen E, Austin J, Weinstein M et al (2008) Care of children isolated for infection control: a prospective observational cohort study. Pediatrics 122:e411–e415
341. Kabbani D, Weir SK, Berg G et al (2013) Cohorting based on nasal methicillin-resistant Staphylococcus aureus status: an opportunity to share more than a room. Am J Infect Control 41:401–404
342. Islam J, Cheek E, Navani V et al (2013) Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence. J Hosp Infect 85:17–21
343. Pittet D, Dharan S, Touveneau S et al (1999) Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 159:821–826
344. Lucet JC, Rigaud MP, Mentre F et al (2002) Hand contamination before and after different hand hygiene techniques: a randomized clinical trial. J Hosp Infect 50:276–280
345. Boyce JM, Potter-Bynoe G, Chenevert C et al (1997) Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 18:622–627
346. Zachary KC, Bayne PS, Morrison VJ et al (2001) Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 22:560–564
347. Sroka S, Gastmeier P, Meyer E (2010) Impact of alcohol hand-rub use on methicillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect 74:204–211
348. Mertz D, Dafoe N, Walter SD et al (2010) Effect of a multifaceted intervention on adherence to hand hygiene among healthcare workers: a cluster-randomized trial. Infect Control Hosp Epidemiol 31:1170–1176
349. McLaws ML, Pantle AC, Fitzpatrick KR et al (2009) More than hand hygiene is needed to affect methicillin-resistant Staphylococcus aureus clinical indicator rates: clean hands save lives, part IV. Med J Aust 191:26–31
350. Eveillard M, Eb F, Tramier B et al (2001) Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J Hosp Infect 47:116–124
351. Jarlier V, Trystram D, Brun-Buisson C et al (2010) Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 170:552–559
352. Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36:281–285
353. Robicsek A, Beaumont JL, Thomson RB Jr et al (2009) Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 30:623–632
354. Miller LG, Tan J, Eells SJ et al (2012) Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 56:1084–1086
355. Wilcox MH, Hall J, Pike H et al (2003) Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 54:196–201
356. Horiuchi A, Nakayama Y, Kajiyama M et al (2006) Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol 101:274–277
357. van Rijen MB, Wenzel R et al. (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev CD006216
358. van Rijen MM,B, Wenzel RP et al (2008) Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 61:254–261
359. Derde LP, Dautzenberg MJ, Bonten MJ (2012) Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 38:931–939
360. Ridenour G, Lampen R, Federspiel J et al (2007) Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 28:1155–1161
361. Sandri AM, Dalarosa MG, Ruschel de Alcantara L et al (2006) Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27:185–187
362. Vernon MO, Hayden MK, Trick WE et al (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166:306–312
363. Ammerlaan H, Kluytmans J, Wertheim H et al (2009) Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 48:922–930
364. Casewell MW, Hill RL (1986) Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’) – a controlled trial. J Antimicrob Chemother 17:365–372
365. Huang SS, Septimus E, Kleinman K et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265
366. Climo M, Yokoe DS, Wareen DK, Perl TM, Bolon M (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542
367. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ (2009) The effect of daily bathing with chlorhexidine on the acquisition of MRSA, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 37:1858–1865
368. Derde LP, Cooper BS, Goossens H (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14:31–39
369. Becker K, Werner G, Friedrich A (2013) MRSA-Screening: Für und wider aktive Surveillance. Dtsch Ärztebl 110:1789–1791
370. Harbarth S, Dharan S, Liassine N et al (1999) Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43:1412–1416
371. Simor AE, Phillips E, McGeer A et al (2007) Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44:178–185
372. Wendt C, Schinke S, Württemberger M et al (2007) Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 28:1036–1043
373. Vasquez JE, Walker ES, Franzus BW et al (2000) The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans’ Affairs hospital. Infect Control Hosp Epidemiol 21:459–464
374. Harbarth S, Liassine N, Dharan S et al (2000) Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31:1380–1385
375. Leigh DA, Joy G (1993) Treatment of familial staphylococcal infection – comparison of mupirocin nasal ointment and chlorhexidine/neomycin (Naseptin) cream in eradication of nasal carriage. J Antimicrob Chemother 31:909–917
376. McAnally TP, Lewis MR, Brown DR (1984) Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 25:422–426
377. Parras F, Guerrero MC, Bouza E et al (1995) Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 39:175–179
378. Soto NE, Vaghjimal A, Stahl-Avicolli A et al (1999) Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization. Infect Control Hosp Epidemiol 20:351–353
379. Pitten FA, Werner HP, Kramer A (2003) A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 55:108–115
380. Hill RL, Casewell MW (2000) The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 45:198–205
381. Segers P, Speekenbrink RG, Ubbink DT et al (2006) Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296:2460–2466
382. Caelli M, Porteous J, Carson CF et al (2000) Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 46:236–237
383. Dryden MS, Dailly S, Crouch M (2004) A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 56:283–286
384. Ansorg RA, Azem T, Fabry WH et al (2002) Influence of mucin on the activity of the antiseptic Lavasept against Staphylococcus aureus. Chemotherapy 48:129–133
385. Hill RL (2002) The bioavailability of mupirocin in nasal secretions in vitro. J Clin Pathol 55:233–235
386. Kramer A, Hoppe H, Krull B et al. (1998) Antiseptic efficacy and acceptance of octenisept computed with common antiseptic mouthwashes. Zentralbl Hyg Umweltmed 200:443–456
387. Pitten FA, Kiefer T, Buth C et al (2003) Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. J Hosp Infect 53:283–291
388. Tomas I, Alvarez M, Limeres J et al (2007) Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia. Infect Control Hosp Epidemiol 28:577–582
389. Clavero J, Baca P, Junco P et al (2003) Effects of 0.2 % chlorhexidine spray applied once or twice daily on plaque accumulation and gingival inflammation in a geriatric population. J Clin Periodontol 30:773–777
390. van Steenberghe D (1997) Breath malodor. Curr Opin Periodontol 4:137–143
391. Kola A, Gastmeier P (2007) Efficacy of oral chlorhexidine in preventing lower respiratory tract infections. Meta-analysis of randomized controlled trials. J Hosp Infect 66:207–216
392. Rohr U, Mueller C, Wilhelm M et al (2003) Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 54:305–309
393. Sloot N, Siebert J, Hoffler U (1999) Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment. Zentralbl Hyg Umweltmed 202:513–523
394. Zafar AB, Butler RC, Reese DJ et al (1995) Use of 0.3 % triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23:200–208
395. Nguyen DM, Mascola L, Brancoft E (2005) Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11:526–532
396. Wilcox MH, Hall J, Gill AB et al (2004) Effectiveness of topical chlorhexidine powder as an alternative to hexachlorophane for the control of Staphylococcus aureus in neonates. J Hosp Infect 56:156–159
397. Kampf G, Kramer A (2004) Eradication of methicillin-resistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients – an open uncontrolled clinical trial. Ann Clin Microbiol Antimicrob 3:9
398. Hamson C, Bignardi GE (2010) MRSA decolonization with Prontoderm compared with chlorhexidine and mupirocin. J Hosp Infect 75:142–143
399. Jappe U, Schnuch A, Uter W (2003) Frequency of sensitization to antimicrobials in patients with atopic eczema compared with nonatopic individuals: analysis of multicentre surveillance data, 1995–1999. Br J Dermatol 149:87–93
400. Karki S, Cheng AC (2012) Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect 82:71–84
401. Loeb MB, Main C, Eady A et al. (2003) Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev (4):CD003340
402. Simon A, Exner M, Kramer A et al. (2009) Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 – current considerations by the DGKH Management Board GMS Krankenhaushyg Interdiszip. 4:Doc2
403. Berthelot P, Grattard F, Fascia P et al (2003) Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit. Infect Control Hosp Epidemiol 24:299–300
404. Bertin ML, Vinski J, Schmitt S et al (2006) Outbreak of methicillin-resistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis. Infect Control Hosp Epidemiol 27:581–585
405. Faibis F, Laporte C, Fiacre A et al (2005) An outbreak of methicillin-resistant Staphylococcus aureus surgical-site infections initiated by a healthcare worker with chronic sinusitis. Infect Control Hosp Epidemiol 26:213–215
406. Kluytmans J, Harbarth S (2009) Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help? Infect Control Hosp Epidemiol 30:633–635
407. Kramer A, Daeschlein G, Kammerlander G et al (2004) Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik. Z Wundheilung 3:110–120
408. Gerber V (2008) Zur Versorgung von Patienten mit chronischen Wunden im Rahmen von Versorgungsnetzwerken. Epidemiol Bull 41:351–353
409. Dietze B, Rath A, Wendt C et al (2001) Survival of MRSA on sterile goods packaging. J Hosp Infect 49:255–261
410. Allen KD, Anson JJ, Parsons LA et al (1997) Staff carriage of methicillin-resistant Staphylococcus aureus (EMRSA 15) and the home environment: a case report. J Hosp Infect 35:307–311
411. Kniehl E, Becker A, Forster DH (2005) Bed, bath and beyond: pitfalls in prompt eradication of methicillin-resistant Staphylococcus aureus carrier status in healthcare workers. J Hosp Infect 59:180–187
412. Forward KR (2010) The value of multiple surveillance cultures for methicillin-resistant Staphylococcus aureus. Am J Infect Control 38:596–599
413. Senn L, Basset P, Nahimana I et al (2012) Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test? Clin Microbiol Infect 18:E31–E33
414. Eckmanns T, Geffers C, Weist K et al (2004) One hour versus 24 h sampling intervals for the screening of patients with methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 57:93–94
415. Darby JM, Linden P, Pasculle W et al (1997) Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med 25:989–994
416. Hoen B, Selton-Suty C, Lacassin F et al (1995) Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 20:501–506
417. Shafazand S, Weinacker AB (2002) Blood cultures in the critical care unit: improving utilization and yield. Chest 122:1727–1736
418. Robert Koch-Institut, Informationen zu regionalen MRE-Netzwerken. http://www.rki.de/DE/Content/Infekt/Krankenhaushygiene/Netzwerke/Netzwerke_node.html. Zugegriffen: April 2014
419. van Cleef BA, Kluytmans JA, van Benthem BH et al (2012) Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PloS One 7:e42787
420. Jurke A, Köck R, Becker K et al (2013) Reduction of the nosocomial methicillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveillance 18:pii=20579
421. Nassauer A (2008) Kontrolle der Weiterverbreitung von MRSA – Personal im Gesundheitsdienst als Carrier. Epidemiol Bull 36:303–311
422. von Baum HD, Föll M et al (2008) Consensus-Empfehlung Baden-Württemberg: Umgang mit MRSA-positivem Personal. Hyg Med 33:25–29
423. Beigi RH (2011) Clinical implications of methicillin-resistant Staphylococcus aureus in pregnancy. Curr Opin Obstet Gynecol 23:82–86
424. Volk L, Thomson T, Chhangani P et al (2011) Methicillin-resistant Staphylococcus aureus nasal colonization among women admitted to labor and delivery and their newborn infants. Infect Control Hosp Epidemiol 32:1045–1046
425. Andrews JI, Fleener DK, Messer SA et al (2009) Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies. Am J Obstet Gynecol 201(396):e391–e395
426. Melendez J, Claxton A, Erskine K (2012) MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong. Arch Gynecol Obstet 285:663–665
427. Acton DS, Plat-Sinnige MJ, van Wamel W et al (2009) Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? Eur J Clin Microbiol Infect Dis 28:115–127
428. Crawford T, Rodvold KA, Solomkin JS (2012) Vancomycin for surgical prophylaxis? Clin Infect Dis 54:1474–1479
429. Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–292
430. American College of Obstetricians and Gynecologists (2011) ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 117:1472–1483
431. Gray JW, Suviste J (2013) Three years’ experience of screening for methicillin-resistant Staphylococcus aureus in obstetrics. J Hosp Infect 83:61–63
432. Bergen P (2012) Informationen zu MRSA und weiteren multiresistenten Erregern für Rehabilitations-Einrichtungen – Eine Empfehlung der MRSA-Netzwerke Niedersachsen. Hyg Med 37:228–237
433. Landesarbeitsgemeinschaft multiresistente Erreger (LARE). http://www.lgl.bayern.de/gesundheit/hygiene/lare/. Zugegriffen: April 2014
434. Fach-Intranet für Mitarbeiter im Öffentlichen Gesundheitsdienst auf Bundes-, Landes- und kommunaler Ebene. www.uminfo.de. Zugegriffen: April 2014